Oxford launches world’s first trial of new Ebola vaccine
IBNS-CMEDIA: The University of Oxford’s Oxford Vaccine Group has launched the world’s first Phase I clinical trial, BD-Ebov, of a vaccine against Bundibugyo ebolavirus (BDBV), in response to the ongoing …
Read More